As a company, we aim to disrupt the status quo in surgical stapling by delivering superior products.
Our body of research is growing everyday with real-world evidence to support the excellent surgical performance of our products. We are committed to ongoing research to evaluate patient
outcomes measures and support comparative studies to assess product performance.
Below please find some examples of our commitment to ongoing research.
In a randomized clinical trial, the AEON Endostapler demonstrated superior clinical results after staple lines were evaluated by a blinded 3rd party evaluator.
The AEON Endostapler is a significantly drier alternative to the Echelon Flex Powered Stapler, producing a much drier staple line and decreasing the need for other bleeding control methods.†
Investigators reported consistent satisfaction
with AEON staple lines.
Staple Line Bleeding
in overall bleeding score
comparing Echelon Flex to AEON
statistically significant findings -
p-value = 0.01
Safe and effective
as presented by Cleveland Clinic.
No intraoperative complications
on 316 AEON reloads deployed.§
Proper 'B' staple formation %
in thick tissue*